Strides Pharma Science Share Price

Strides Pharma Corporate Action

CMP as on 19-Aug-22 15:58

₹ 350.10
-8.15 -2.27%

Open

₹ 358.25

Turnover (lac)

₹ 1,290

Prev. Close

₹ 358.25

Day's Vol (shares)

₹ 3,68,584

Day's Range (₹)

₹ 346.25
₹ 360.00

CMP as on19-Aug-22 15:57

₹ 350.00
-7.9 -2.21%

Open

₹ 363.00

Turnover (lac)

₹ 140

Prev. Close

₹ 357.90

Day's Vol (shares)

₹ 16,537

Day's Range

₹ 346.30
₹ 363.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 22-Jul-2022 - -
Quarterly Results Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2022 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday, July 29, 2022, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2022, amongst other matters. Further, as per the provisions of the Companys Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company is closed from Friday, July 1, 2022, upto Sunday, July 31, 2022 (both days inclusive). This is for your kind information and record purposes. (As Per BSE Announcement Dated on 22.07.2022) Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2022 (As per BSE Announcement Dated on 29/07/2022)
Board Meeting - 20-Jul-2022 - -
Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022 inter alia to consider and approve Intimation of raising of funds by way of issuance of Non-Convertible Debentures under Regulation 29 of SEBI Listing Regulations. Outcome of Meeting of the Committee of the Board of Directors of the Company held on Monday, July 25, 2022 (As per BSE Announcement Dated on 25/07/2022)
Board Meeting - 16-May-2022 - -
Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31 2022 and recommendation of dividend if any amongst other matters. Outcome of Board Meeting - Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2022 (As per BSE Announcement Dated on 24/5/2022)
Board Meeting - 29-Mar-2022 - -
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Board Meeting - 21-Jan-2022 - -
Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 inter alia to consider and approve This is to inform you that meeting of Board of Directors of the Company is scheduled to be held on Friday January 28 2022 to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter and nine months ended December 31 2021 amongst other matters. Further as per the provisions of the Companys Code of Conduct for Prohibition of Insider Trading trading window for designated persons of the Company is closed and shall open after 48 hrs post declaration of financial results by the Company. This is for your kind information and record purposes. The Board Meeting to be held on 28/01/2022 has been revised to 10/02/2022 We refer to our letter dated January 21, 2022, regarding intimation of the date of Board Meeting of the Company scheduled to be held on January 28, 2022, inter alia, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter and nine months ended December 31, 2021. Due to unavoidable circumstances, the said meeting has been rescheduled and will now be held on Thursday, February 10, 2022. As per the provisions of the Companys Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company is closed and shall open after 48 hrs post declaration of financial results by the Company. This is for your kind information and record purposes. (As per BSE Announcement Dated on 27/01/2022) We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and nine months ended December 31, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The board meeting commenced at 11:30 hrs and concluded at 13:10 hrs. This is for your information and record. Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) (As Per BSE Announcement Dated on 10/02/2022)
Board Meeting - 28-Jan-2022 - -
Allotment of shares under Strides ESOP 2016 Plan
Board Meeting - 03-Nov-2021 - -
Quarterly Results We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and half year ended September 30, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The board meeting commenced at 11:00 hrs and concluded at 13:30 hrs. This is for your information and record. (As Per BSE Announcement Dated on 10/11/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity